How does taking Sotorasib work?
Sotorasib is a new anti-cancer drug used to treat KRAS G12C mutated non-small cell lung cancer (NSCLC). For patients with this specific genetic mutation, sotoraxib has shown some promise in clinical trials.
First of all, the mechanism of action of sotoraxib is to block abnormal signaling pathways in cancer cells by inhibiting KRAS G12C mutant. This precise targeted treatment mechanism makes the drug more targeted and more effective in intervening in the development of tumors.

In clinical trials, sotorasiib showed significant therapeutic effects in some patients with KRAS G12Cmutant non-small cell lung cancer. Research results show that some patients' tumor growth was inhibited after using sotoraxib, and some even experienced tumor shrinkage. This provides a first-line treatment option for patients with KRAS G12C mutated non-small cell lung cancer, which was once considered difficult to effectively intervene.
However, the effects of the drug may vary between individuals, and clinical trials are still in the early stages and more long-term studies are needed to confirm efficacy and safety. Patients need to closely follow their doctor's advice when using sotoraxib and undergo regular testing and evaluation of treatment effects. Some patients may experience side effects during use, such as fatigue, nausea, diarrhea, etc., so doctors will closely monitor the patient's response and adjust the treatment plan.
The original drug of sotorasibu has not yet been launched in China, so patients cannot purchase it domestically and need to purchase sotorasibu through overseas channels. The price of the original version of sotorasibu in Hong Kong, China, with the specifications of 120mg*240 tablets, is around 8 million, and the price of the European version of the original drug with the same specifications is around 4 million, which is relatively expensive. The cheaper ones are the generic drugs marketed abroad. For example, the price of generic drugs in Laos and Bangladesh is around two to three thousand yuan. The price is relatively cheap, and the ingredients of foreign generic drugs are basically the same as the original drugs.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)